考虑到lncRNA HOTAIR的转录活性,E2F1通过表观遗传沉默KLF16/Klotho在血管钙化中的作用。

IF 4.1 2区 医学 Q1 PERIPHERAL VASCULAR DISEASE
Journal of Hypertension Pub Date : 2025-11-01 Epub Date: 2025-09-03 DOI:10.1097/HJH.0000000000004104
Yanxia Chen, Ben Ke, Minzi Qiu, Chen Yan, Honghong Zou, Wei Tu
{"title":"考虑到lncRNA HOTAIR的转录活性,E2F1通过表观遗传沉默KLF16/Klotho在血管钙化中的作用。","authors":"Yanxia Chen, Ben Ke, Minzi Qiu, Chen Yan, Honghong Zou, Wei Tu","doi":"10.1097/HJH.0000000000004104","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Vascular calcification is a significant complication in patients with chronic kidney disease (CKD), which is closely related to hyperphosphatemia. However, its mechanism has not been fully elucidated yet. We mainly investigated the novel role and mechanism of transcription factor E2F transcription factor 1 (E2F1) by targeting lncRNA HOX transcript antisense intergenic RNA (HOTAIR) in high phosphate (Pi)-induced vascular calcification.</p><p><strong>Methods: </strong>Differential expressions of several candidates in E2F transcription factor family were assessed by RT-qPCR and Western blot analysis in both in-vitro and in-vivo models.Calcification of human aortic smooth muscle cells (HASMCs) was evaluated through Alizarin Red S staining, measurement of Ca 2+ content, and assessment of alkaline phosphatase (ALP) activity. Subcellular localization of HOTAIR was detected utilizing subcellular fractionation and fluorescent in-situ hybridization (FISH). Chromatin immunoprecipitation (ChIP), luciferase reporter and RNA immunoprecipitation (RIP) assays were performed to validate the role of E2F1/HOTAIR in Krüppel-like factor 16 (KLF16)/Klotho axis. Concentrations of serum creatinine (Scr) and urine nitrogen (BUN) were measured to assess renal function in mice, followed by the evaluation of vascular calcification in mouse aorta ring.</p><p><strong>Results: </strong>E2F1, identified as significantly downregulated in HASMCs following Pi treatment, was found to be a transcriptional activator of HOTAIR. E2F1 overexpression attenuated Pi-induced HASMCs calcification, which was reversed by HOTAIR silencing. HOTAIR acted as a scaffold for lysine-specific demethylase 1A (KDM1A) and enhancer of zeste homolog 2 (EZH2), contributing to the epigenetic suppression of KLF16. KLF16, in turn, acted as a transcriptional inhibitor for Klotho, thereby suppressing Pi-triggered HASMCs calcification. Additionally, E2F1 overexpression alleviated calcium deposition in thoracic aorta of Pi-induced mice, which was overturned after HOTAIR silencing.</p><p><strong>Conclusion: </strong>HOTAIR, transcriptionally activated by E2F1, exerts a protective effect against vascular calcification by modulating KLF16/Klotho axis. This protective mechanism involves recruitment of KDM1A and EZH2. These findings provide potential new therapeutic targets for CKD treatment.</p>","PeriodicalId":16043,"journal":{"name":"Journal of Hypertension","volume":" ","pages":"1802-1815"},"PeriodicalIF":4.1000,"publicationDate":"2025-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Role of E2F1 , taking account for the transcriptional activity of lncRNA HOTAIR , in vascular calcification via epigenetic silencing of KLF16/Klotho.\",\"authors\":\"Yanxia Chen, Ben Ke, Minzi Qiu, Chen Yan, Honghong Zou, Wei Tu\",\"doi\":\"10.1097/HJH.0000000000004104\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Background: </strong>Vascular calcification is a significant complication in patients with chronic kidney disease (CKD), which is closely related to hyperphosphatemia. However, its mechanism has not been fully elucidated yet. We mainly investigated the novel role and mechanism of transcription factor E2F transcription factor 1 (E2F1) by targeting lncRNA HOX transcript antisense intergenic RNA (HOTAIR) in high phosphate (Pi)-induced vascular calcification.</p><p><strong>Methods: </strong>Differential expressions of several candidates in E2F transcription factor family were assessed by RT-qPCR and Western blot analysis in both in-vitro and in-vivo models.Calcification of human aortic smooth muscle cells (HASMCs) was evaluated through Alizarin Red S staining, measurement of Ca 2+ content, and assessment of alkaline phosphatase (ALP) activity. Subcellular localization of HOTAIR was detected utilizing subcellular fractionation and fluorescent in-situ hybridization (FISH). Chromatin immunoprecipitation (ChIP), luciferase reporter and RNA immunoprecipitation (RIP) assays were performed to validate the role of E2F1/HOTAIR in Krüppel-like factor 16 (KLF16)/Klotho axis. Concentrations of serum creatinine (Scr) and urine nitrogen (BUN) were measured to assess renal function in mice, followed by the evaluation of vascular calcification in mouse aorta ring.</p><p><strong>Results: </strong>E2F1, identified as significantly downregulated in HASMCs following Pi treatment, was found to be a transcriptional activator of HOTAIR. E2F1 overexpression attenuated Pi-induced HASMCs calcification, which was reversed by HOTAIR silencing. HOTAIR acted as a scaffold for lysine-specific demethylase 1A (KDM1A) and enhancer of zeste homolog 2 (EZH2), contributing to the epigenetic suppression of KLF16. KLF16, in turn, acted as a transcriptional inhibitor for Klotho, thereby suppressing Pi-triggered HASMCs calcification. Additionally, E2F1 overexpression alleviated calcium deposition in thoracic aorta of Pi-induced mice, which was overturned after HOTAIR silencing.</p><p><strong>Conclusion: </strong>HOTAIR, transcriptionally activated by E2F1, exerts a protective effect against vascular calcification by modulating KLF16/Klotho axis. This protective mechanism involves recruitment of KDM1A and EZH2. These findings provide potential new therapeutic targets for CKD treatment.</p>\",\"PeriodicalId\":16043,\"journal\":{\"name\":\"Journal of Hypertension\",\"volume\":\" \",\"pages\":\"1802-1815\"},\"PeriodicalIF\":4.1000,\"publicationDate\":\"2025-11-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Journal of Hypertension\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1097/HJH.0000000000004104\",\"RegionNum\":2,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2025/9/3 0:00:00\",\"PubModel\":\"Epub\",\"JCR\":\"Q1\",\"JCRName\":\"PERIPHERAL VASCULAR DISEASE\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Hypertension","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1097/HJH.0000000000004104","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/9/3 0:00:00","PubModel":"Epub","JCR":"Q1","JCRName":"PERIPHERAL VASCULAR DISEASE","Score":null,"Total":0}
引用次数: 0

摘要

背景:血管钙化是慢性肾脏疾病(CKD)患者的重要并发症,与高磷血症密切相关。然而,其机制尚未完全阐明。我们主要通过靶向lncRNA HOX转录反义基因间RNA (HOTAIR)研究转录因子E2F转录因子1 (E2F1)在高磷酸盐(Pi)诱导的血管钙化中的新作用和机制。方法:采用RT-qPCR和Western blot分析方法,在体外和体内模型中评估几种候选E2F转录因子家族的差异表达。通过茜素红S染色、钙离子含量测定和碱性磷酸酶(ALP)活性评估人主动脉平滑肌细胞(HASMCs)的钙化程度。利用亚细胞分离和荧光原位杂交(FISH)检测HOTAIR的亚细胞定位。采用染色质免疫沉淀法(ChIP)、荧光素酶报告基因法和RNA免疫沉淀法(RIP)验证E2F1/HOTAIR在kr pel样因子16 (KLF16)/Klotho轴中的作用。测定血清肌酐(Scr)和尿氮(BUN)浓度,评估小鼠肾功能,并评估小鼠主动脉环血管钙化情况。结果:经Pi处理后,发现在HASMCs中显著下调的E2F1是HOTAIR的转录激活因子。E2F1过表达可减弱pi诱导的HASMCs钙化,而HOTAIR沉默可逆转这一过程。HOTAIR作为赖氨酸特异性去甲基酶1A (KDM1A)的支架和zeste同源物2 (EZH2)的增强子,参与KLF16的表观遗传抑制。KLF16反过来作为Klotho的转录抑制剂,从而抑制pi触发的HASMCs钙化。此外,E2F1过表达减轻了pi诱导小鼠胸主动脉钙沉积,HOTAIR沉默后这一现象被逆转。结论:HOTAIR由E2F1转录激活,通过调节KLF16/Klotho轴对血管钙化具有保护作用。这种保护机制涉及KDM1A和EZH2的募集。这些发现为CKD的治疗提供了潜在的新靶点。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
Role of E2F1 , taking account for the transcriptional activity of lncRNA HOTAIR , in vascular calcification via epigenetic silencing of KLF16/Klotho.

Background: Vascular calcification is a significant complication in patients with chronic kidney disease (CKD), which is closely related to hyperphosphatemia. However, its mechanism has not been fully elucidated yet. We mainly investigated the novel role and mechanism of transcription factor E2F transcription factor 1 (E2F1) by targeting lncRNA HOX transcript antisense intergenic RNA (HOTAIR) in high phosphate (Pi)-induced vascular calcification.

Methods: Differential expressions of several candidates in E2F transcription factor family were assessed by RT-qPCR and Western blot analysis in both in-vitro and in-vivo models.Calcification of human aortic smooth muscle cells (HASMCs) was evaluated through Alizarin Red S staining, measurement of Ca 2+ content, and assessment of alkaline phosphatase (ALP) activity. Subcellular localization of HOTAIR was detected utilizing subcellular fractionation and fluorescent in-situ hybridization (FISH). Chromatin immunoprecipitation (ChIP), luciferase reporter and RNA immunoprecipitation (RIP) assays were performed to validate the role of E2F1/HOTAIR in Krüppel-like factor 16 (KLF16)/Klotho axis. Concentrations of serum creatinine (Scr) and urine nitrogen (BUN) were measured to assess renal function in mice, followed by the evaluation of vascular calcification in mouse aorta ring.

Results: E2F1, identified as significantly downregulated in HASMCs following Pi treatment, was found to be a transcriptional activator of HOTAIR. E2F1 overexpression attenuated Pi-induced HASMCs calcification, which was reversed by HOTAIR silencing. HOTAIR acted as a scaffold for lysine-specific demethylase 1A (KDM1A) and enhancer of zeste homolog 2 (EZH2), contributing to the epigenetic suppression of KLF16. KLF16, in turn, acted as a transcriptional inhibitor for Klotho, thereby suppressing Pi-triggered HASMCs calcification. Additionally, E2F1 overexpression alleviated calcium deposition in thoracic aorta of Pi-induced mice, which was overturned after HOTAIR silencing.

Conclusion: HOTAIR, transcriptionally activated by E2F1, exerts a protective effect against vascular calcification by modulating KLF16/Klotho axis. This protective mechanism involves recruitment of KDM1A and EZH2. These findings provide potential new therapeutic targets for CKD treatment.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
Journal of Hypertension
Journal of Hypertension 医学-外周血管病
CiteScore
7.90
自引率
6.10%
发文量
1389
审稿时长
3 months
期刊介绍: The Journal of Hypertension publishes papers reporting original clinical and experimental research which are of a high standard and which contribute to the advancement of knowledge in the field of hypertension. The Journal publishes full papers, reviews or editorials (normally by invitation), and correspondence.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信